Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boeing Co (BA) vs Viatris Inc (VTRS) Price & Performance

Viatris IncTrade

Price performance (Past 24H)

Key statistics

Boeing Co vs Viatris Inc — how do they compare? Boeing Co trades at $233.59 (market cap $184.35B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Boeing Co is far larger — about 9.9× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

BAVTRS
Market Cap
$184.35B$18.69B
Volume
7,591,579
Sector
IndustrialsHealth
52-Week High
$252.15$17.86
52-Week Low
$179.12$9.49
Enterprise Value
$210.23B$30.80B
Dividend Yield
0.03%2.95%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boeing Co

The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.

Read more on BA

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS